 |
 |
|
|
RESÚMENES DICIEMBRE 2008 |
Other Neuropsychiatric Disorders & General Information
(Haga un click en la
información del journal para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 –
revisión, abierto, básico; 2 – casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
5 - Olanzapine for the treatment of borderline personality
disorder: variable dose 12-week randomised double-blind placebo-controlled
study
S. Charles Schulz, Mary C. Zanarini, Anthony Bateman, Martin Bohus,
Holland C. Detke, Quynh Trzaskoma, Yoko Tanaka, and Daniel Lin, Walter Deberdt, Sara Corya
The British Journal of Psychiatry (2008) 193:
485-492
3! - The Structure of
Genetic and Environmental Risk Factors for DSM-IV Personality
Disorders. A Multivariate Twin Study
Kenneth S. Kendler, Steven H. Aggen, Nikolai Czajkowski,
Espen Røysamb, Kristian Tambs, Svenn Torgersen,
Michael C. Neale, Ted Reichborn-Kjennerud
Arch Gen Psychiatry. 2008;65(12):1438-1446
GRATIS 3!
- Diagnosis and treatment of dementia: 6. Management of severe Alzheimer
disease
Nathan Herrmann, and Serge Gauthier
CMAJ
• December 2, 2008; 179 (12)
5 - Efficacy of Osmotic-Release Oral System (OROS)
Methylphenidate for Mothers With
Attention-Deficit/Hyperactivity Disorder (ADHD): Preliminary Report of Effects
on ADHD Symptoms and Parenting
Andrea Chronis-Tuscano, Karen E. Seymour, Mark
A. Stein, Heather A. Jones, Cynthia D. Jiles, Mary E.
Rooney, Charles J. Conlon, Lisa A. Efron, Stephanie
A. Wagner, Jessica Pian, and Adelaide S. Robb
J Clin Psychiatry December 2, 2008: e1-e10
3 - Depression in Parkinson's Disease. Part
1: Epidemiology, Signs and Symptoms, Pathophysiology and Diagnosis
A. Storch, G.
Ebersbach, G. Fuchs, W. H. Jost, P. Odin, G. Reifschneider, M. Bauer
Fortschr Neurol Psychiatr 2008; 76: 715-724
5 - Attention-Deficit/Hyperactivity Disorder-Specific
Quality of Life With Triple-Bead Mixed Amphetamine
Salts (SPD465) in Adults: Results of a Randomized, Double-Blind,
Placebo-Controlled Study
Thomas J. Spencer, Jeanne M. Landgraf, Lenard
A. Adler, Richard H. Weisler, Colleen S. Anderson,
and Sharon H. Youcha
J Clin Psychiatry
2008;69:1766-1775
3! - Benzodiazepine and opioid use and the
duration of intensive care unit delirium in an older population
Pisani,
Margaret A; Murphy, Terrence E; Araujo, Katy L. B; Slattum, Patricia; Van Ness, Peter H; Inouye, Sharon K
Critical
Care Medicine. 28 November 2008
3 - The use of
alternative medicine for the treatment of insomnia in the elderly
E. Paul CHERNIACK
Psychogeriatrics. Volume 6 Issue
1, Pages 21 - 30
5< - A Double-blind
Placebo-controlled Discontinuation Study of Zuclopenthixol
for the Treatment of Aggressive Disruptive Behaviours in Adults with Mental
Retardation - Secondary Parameter Analyses
F. Häßler, T. Glaser, A. F. Pap, M. Beneke, A. Diefenbacher,O. Reis and the Zuclopenthixol
Disruptive Behaviour Study Group
Pharmacopsychiatry 2008;
41: 232-239
5 - Safety and
efficacy of galantamine (Reminyl)
in severe Alzheimer's disease (the SERAD study): a randomised,
placebo-controlled, double-blind trial
Alistair Burns, Roberto Bernabei,
Roger Bullock, Alfonso J Cruz Jentoft, Lutz Frölich, Christoph Hock, Minna Raivio, Eric Triau, Maurits Vandewoude, Anders Wimo,
Elizabeth Came, Bart Van Baelen, Gerry L Hammond, Joop C van Oene and Susanne Schwalen
The Lancet Neurology. Volume 8, Issue 1, January 2009, Pages 39-47
3 - Neuroenhancement:
status quo and perspectives
Claus Normann and
Mathias Berger
3 - Withdrawing Benzodiazepines in Primary
Care
Lader, Malcolm; Tylee,
Andre; Donoghue, John
3! - Getting into the
Brain: Approaches to Enhance Brain Drug Delivery
Patel, Mayur M; Goyal, Bhoomika R; Bhadada, Shraddha V; Bhatt, Jay
S; Amin, Avani F
5< - A Double-blind
Placebo-controlled Discontinuation Study of Zuclopenthixol
for the Treatment of Aggressive Disruptive Behaviours in Adults with Mental
Retardation - Secondary Parameter Analyses
Häßler F, Glaser T, Pap AF, Beneke M, Diefenbacher A, Reis O
Pharmacopsychiatry. 2008 Nov;41(6):232-239.
Epub 2008 Dec 9
GRATIS 3!
- Hospital Stays Related to Mental Health, 2006
HCUP Statistical Brief #62. October 2008. Agency for Healthcare Research and
Quality, Rockville, MD
3 - Chronic fatigue syndrome and DSM-IV personality disorders
, , , ,
J Psychosom Res. Volume 66, Issue 1, Pages 13-20 (January 2009)
4 - Suicidality in a placebo-controlled fluoxetine study of body dysmorphic
disorder
Phillips, Katharine A;
Kelly, Megan M
International Clinical
Psychopharmacology. 24(1):26-28,
January 2009
5< - Simulated
Driving Changes in Young Adults With ADHD Receiving
Mixed Amphetamine Salts Extended Release and Atomoxetine
Gary G.
Kay, M. Alex Michaels, Barton Pakull
Journal
of Attention Disorders, Vol. 12, No. 4, 316-329 (2009)
3! - Untreated
ADHD in Adults. Are There Sex
Differences in Symptoms, Comorbidity, and Impairment?
Kirsten
Rasmussen, Sten Levander
Journal
of Attention Disorders, Vol. 12, No. 4, 353-360 (2009)
3! - Statins are associated with
a reduced risk of Alzheimer disease regardless of lipophilicity.
The
Mendel D M Haag, Albert Hofman, Peter J Koudstaal, Bruno H C Stricker and Monique M B Breteler
J Neurol Neurosurg
Psychiatry. Published Online First: 17
October 2008
GRATIS 3!
- What Principles Should Guide Treatment
Effectiveness Study?
The AMA House of Delegates
Reports of The Council on
Medical Services
5 - Next-day residual effects of gaboxadol and flurazepam
administered at bedtime: a randomized double-blind study in healthy elderly
subjects
Julia Boyle, Dennis
Wolford, Cynthia Gargano, Jacqueline McCrea, Corinne
Cummings, Kristine Cerchio, Christopher Lines
Human
Psychopharmacology: Clinical and Experimental. Volume 24 Issue
1, Pages 61 - 71
GRATIS 3!
- The Prevalence of
Mental Disorders among the Homeless in Western Countries: Systematic Review and
Meta-Regression Analysis
Fazel S, Khosla V, Doll H, Geddes J
3 - Efficacy
of a Vitamin/Nutriceutical Formulation for
Early-stage Alzheimer's Disease: A 1-year, Open-label
Pilot Study With an 16-Month Caregiver Extension
Amy Chan,
James Paskavitz, Ruth Remington, Shelly Rasmussen,
Thomas B. Shea
American
Journal of Alzheimer's Disease and Other Dementias®,
Vol. 23, No. 6, 571-585 (2009)
5 - Milnacipran for the treatment of fibromyalgia in adults: A
15-week, multicenter, randomized, double-blind, placebo-controlled,
multiple-dose clinical trial
Daniel J. Clauw,
Philip Mease, Robert H. Palmer, R. Michael Gendreau and Yong Wang
Clinical
Therapeutics. Volume 30, Issue 11, November 2008, Pages 1988-2004
3 - Multifunctional Receptor-Directed Drugs for
Disorders of the Central Nervous System
Jerry J. Buccafusco
Neurotherapeutics. Volume
6, Issue 1, January 2009, Pages 4-13
3 - Memoquin: A Multi-Target–Directed
Ligand as an Innovative Therapeutic
Maria Laura Bolognesi, Andrea Cavalli and Carlo Melchiorre
Neurotherapeutics. Volume
6, Issue 1, January 2009, Pages 152-162
3 - Multifunctional Neuroprotective
Derivatives of Rasagiline as Anti-Alzheimer's Disease
Drugs
Orly Weinreb,
Silvia Mandel, Orit Bar-Am, Merav Yogev-Falach,
Yael Avramovich-Tirosh, Tamar Amit and Moussa
B.H. Youdim
Neurotherapeutics. Volume
6, Issue 1, January 2009, Pages 163-174
3 - Novel Anti-Alzheimer's Dimer
Bis(7)-Cognitin: Cellular and Molecular Mechanisms of Neuroprotection Through Multiple Targets
Wenming Li, Marvin Mak, Hualiang Jiang, Qinwen Wang, Yuanping Pang, Kaixian Chen and Yifan Han
Neurotherapeutics. Volume
6, Issue 1, January 2009, Pages 187-201
3 - Effects of parental mental illness on children
Cressida Manning and Alain Gregoire
Psychiatry. Volume
8, Issue 1, January 2009, Pages 7-9
3 - Pharmacological management and ECT in
childbearing women with psychiatric disorders
Angelika Wieck and Alain
Gregoire
Psychiatry. Volume
8, Issue 1, January 2009, Pages 33-37
3 - Low Serum
Cholesterol May Be Associated
With Suicide Attempt History
M. Mercedes Perez-Rodriguez, Enrique Baca-Garcia,
Carmen Diaz-Sastre, Eloy Garcia-Resa, Antonio Ceverino, Jeronimo Saiz-Ruiz, Maria A.
Oquendo, and Jose de Leon
J Clin Psychiatry
2008;69:1920-1927
5 - Efficacy of Osmotic-Release
Oral System (OROS) Methylphenidate
for Mothers With Attention-Deficit/Hyperactivity Disorder (ADHD): Preliminary Report of Effects
on ADHD Symptoms and Parenting
Andrea Chronis-Tuscano, Karen E. Seymour, Mark A. Stein, Heather A. Jones,
Cynthia D. Jiles, Mary E. Rooney, Charles J. Conlon, Lisa
A. Efron, Stephanie A.
Wagner, Jessica Pian, and Adelaide
S. Robb
J Clin Psychiatry
2008;69:1938-1947
GRATIS 3
- Selective Histamine
H1 Antagonism: Novel Hypnotic and Pharmacologic Actions Challenge Classical
Notions of Antihistamines
Stephen M. Stahl
CNS Spectr. 2008;13(12):1047-1055
| Regresar a RESÚMENES DICIEMBRE 2008 |